Medicalook
Medicalook

Lotensin

http://www.medicalook.com
Lotensin

Lotensin review





Lotensin is part of the family of medications commonly known as ACE inhibitors, which is an acronym for angiotensin converting enzyme. Lotensin is used in the treatment of hypertension and can be prescribed in its generic form, benazepril.

Lotensin has not been approved for all patients and come patients with other health conditions may not be able to tolerate the medication without adverse affects. A thorough medical history is strongly encouraged before writing a prescription for Lotensin. Patients with a medical history which includes a previous serious reaction to an ACE inhibitor, liver disease, dialysis, kidney disease, diabetes, heart disease,, congestive heart failure, or connective tissue disorders may not be able to tolerate Lotensin or may require additional care, monitoring, tests, or dosing while undergoing drug therapy with this medication.

Lotensin was evaluated by the American Food and Drug Administration and was rated a category D pregnancy risk. This means that Lotensin is likely to cause harm or birth defects in unborn babies. Lotensin has been proven to pass into a mother’s breast milk and can affect or cause harm to a nursing baby. Women who are pregnant or nursing should not take Lotensin and women who suspect they may be pregnant should call the prescribing physician immediately.

Lotensin can only be taken as directed and patients should never alter their own dosage. Changing the dose without a physician’s consent, taking a double dose to make up for a missed dose, and taking doses too closely together can cause an overdose which would require immediate emergency medical attention. Should the patient miss a dose, the dose of Lotensin should be taken as soon as possible unless it is nearing time for the next scheduled dose. To avoid the possibility of an overdose, the missed dose should be skipped if there is insufficient time between doses. An overdose may inflict symptoms upon the patient such as extreme dizziness or fatigue, lightheadedness, and fainting.

Lotensin presents a risk of side effects, some of which might be quite severe. Patients who experience either a serious side effect or an allergic reaction require medical attention without delay to avoid health complications. Symptoms such as swelling of the face, lips, mouth, tongue, or throat typically indicate an allergic reaction to Lotensin. Additionally, symptoms such as lightheadedness, fainting, a decrease in the ability to urinate, no urine output, pale skin, unexplained bruising or bleeding, fever, chills, body aches, flu symptoms, chest pain, edema, swelling, rapid weight gain, a severe rash with peeling, blistering, or inflammation, jaundice, severe fatigue, pounding heart rate, uneven heart beat, and muscle weakness require prompt medical assessment.

Most patients who take Lotensin are more likely to experience side effects that are less serious and do not require medical attention. Patients who experience symptoms such as cough, constipation, nausea, vomiting, headaches, dizziness, drowsiness, or a mild skin rash with itching should simply report their side effects to the prescribing physician. In some cases, patients who experience uncomfortable side effects such as these may be able to take a lower dosage of Lotensin in order to alleviate some symptoms.

Lotensin may interact with other medications and should never be taken in conjunction with these medications. Patients who regularly take Lotensin or any other medication should consult their physician or pharmacist before taking any new medications, including over the counter drugs, prescriptions, herbal remedies, and vitamin supplements. Medications with known interactions with Lotensin include lithium, diuretics, and potassium supplements. Patients taking Lotensin should not use salt substitutes that contain potassium or any other potassium heavy product.

Patients who are taking Lotensin should avoid alcoholic beverages as well as medications that may cause lightheadedness or drowsiness. Lotensin might cause thought and reaction impairments and patients should exercise care when operating machinery or driving a car.

Lotensin has the following structural formula:

Chemical structure of lotensin


• Molecular formula of lotensin is C24H28N2O5
• Chemical IUPAC Name is 2-[4-(1-ethoxycarbonyl-3-phenyl-propyl)amino-5-oxo-6- azabicyclo[5.4.0]undeca-7,9,11-trien-6-yl]acetic acid
• Molecular weight is 424.49 g/mol
Lotensin available : 5mg tablets, 10mg tablets, 20mg tablets, 40mg tablets

Generic name: Benazepril

Brand name(s): Benazeprilum, Briem, Cibacen, Cibacene, Lotrel

  Your Lotensin review